Menu

Hemab Therapeutics Holdings, Inc. (COAG) Q3 2026 Earnings Call Transcript
📰

Hemab Therapeutics Holdings, Inc. (COAG) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·5 days ago
#sOCX0WnJ
#seekingalpha#call#research#hemab#forward
Reading 0:00
15s threshold

Hemab Therapeutics Holdings, Inc. ( COAG ) Q3 2026 Earnings Call November 10, 2026 8:00 AM EST

Company Participants

Benny Sorensen - President, CEO & Director

Mads Behrndt-Eriksen - CFO & GM

Conference Call Participants

David Nierengarten - Wedbush Securities Inc., Research Division

Jin Law - Goldman Sachs Group, Inc., Research Division

Maurice Raycroft - Jefferies LLC, Research Division

Joyce Zhou - JPMorgan Chase & Co, Research Division

Gaurav Maini - LifeSci Capital, LLC, Research Division

Michael King - Rodman & Renshaw Research

Presentation

Operator

Welcome to Hemab Therapeutics Third Quarter 2026 Conference Call. Leading the call from management are Benny Sorensen, Chief Executive Officer; and Mads Behrndt, Chief Financial Officer.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.